facebook pixel
We’re committed to developing potentially transformational medicines to address the needs of patients with hematologic malignancies. With more than 90 abstracts, we’re sharing the latest data from our industry-leading portfolio at #ASH24: t.co/ErhqNhYpJY #JNJOncology t.co/mjL5cJ9up7
https://twitter.com/JNJInnovMed/status/1858891971894423960
Posted on Twitter/X ·

 2

 431

Credits
Suggested Credits

Credits on Gondola describe each credited role and may be incomplete. A brand or featured person is not necessarily the creator.

Tags, Events, and Projects